Page: Viewing Company

Home Icon Home SEC Icon SEC
Create Alert

Viewing Company

Edit Company
Company Name: PAXMEDICA, INC.
CIK: 1811623
Phone: None
Fiscal Year End: None
Entity Type:
SIC: -
Category Type:
Entity Name: None
First Filing Date: 2022-09-30
Last Filing Date: 2024-09-20
SEC Filings
Start End Frame Filed ACCN Value View
2022-04-01 2022-06-30 CY2021Q2 2022-09-30 0001410578-22-002846 $ 6,913,492 View
2022-07-01 2022-09-30 CY2022Q3 2022-11-14 0001410578-22-003388 $ 300,000 View
2022-01-01 2022-12-31 CY2022 2023-03-30 0001558370-23-004966 $ 2,600,000 View
2023-01-01 2023-03-31 CY2023Q1I 2023-05-15 0001558370-23-009939 $ 237,600 View
2023-04-01 2023-06-30 CY2023Q2I 2023-08-09 0001558370-23-014312 $ -45,885 View
2023-07-01 2023-09-30 CY2023Q3I 2023-11-16 0001558370-23-019143 $ 500,000 View
2024-01-01 2023-12-31 CY2024Q1 2024-05-13 0001558370-24-007980 $ 787,981 View
2023-01-01 2023-12-31 CY2023 2024-03-11 0001558370-24-002911 $ 7,207 View
2024-01-01 2024-06-30 CY2024Q2I 2024-09-20 0001558370-24-012929 $ 0 View
SEC Facts By Type
Type Name Description View
us-gaap Restricted Stock, Value, Shares Issued Net of Tax Withholdings Value, after value of shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation. View
us-gaap Other Inventory, in Transit, Gross Gross amount of merchandise or supplies to which the entity holds the title but does not hold physical possession because the goods are currently being transported. View
us-gaap Accrued Salaries, Current Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Deferred Tax Assets, Net of Valuation Allowance Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. View
us-gaap Accounts Payable, Related Parties, Current Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Common Stock, Value, Outstanding Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares. View
us-gaap Net Income (Loss) Available to Common Stockholders, Basic Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. View
us-gaap Nonoperating Income (Expense) The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). View
us-gaap Operating Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. View
us-gaap Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues. View
us-gaap Other Nonoperating Expense Amount of expense related to nonoperating activities, classified as other. View
us-gaap Paid-in-Kind Interest Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method. View
us-gaap Preferred Stock, Liquidation Preference, Value Value of the difference between preference in liquidation and the par or stated values of the preferred shares. View
us-gaap Preferred Stock, Par or Stated Value Per Share Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. View
us-gaap Preferred Stock, Shares Authorized The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. View
us-gaap Payment, Tax Withholding, Share-based Payment Arrangement Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement. View
dei Entity Common Stock, Shares Outstanding Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. View
dei Entity Public Float The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter. View
us-gaap Accounts Payable, Current Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Amortization of Debt Discount (Premium) Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense. View
us-gaap Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. View
us-gaap Assets Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. View
us-gaap Assets, Current Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. View
us-gaap Cash and Cash Equivalents, at Carrying Value Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. View
us-gaap Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Cash Equivalents, at Carrying Value Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. View
us-gaap Class of Warrant or Right, Outstanding Number of warrants or rights outstanding. View
us-gaap Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock. View
us-gaap Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws. View
us-gaap Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. View
us-gaap Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. View
us-gaap Debt Instrument, Face Amount Face (par) amount of debt instrument at time of issuance. View
us-gaap Deferred Costs, Noncurrent Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent. View
us-gaap Dilutive Securities, Effect on Basic Earnings Per Share Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise stock options, restrictive stock units (RSUs), convertible preferred stock of an employee stock ownership plan (ESOP), and other dilutive convertible securities. View
us-gaap Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. View
us-gaap Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. View
us-gaap Employee-related Liabilities, Current Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options. View
us-gaap Fair Value Adjustment of Warrants Amount of expense (income) related to adjustment to fair value of warrant liability. View
us-gaap General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. View
us-gaap Increase (Decrease) in Accrued Liabilities The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. View
us-gaap Increase (Decrease) in Deferred Charges The increase (decrease) during the reporting period in the value of expenditures made during the current reporting period for benefits that will be received over a period of years. Deferred charges differ from prepaid expenses in that they usually extend over a long period of time and may or may not be regularly recurring costs of operation. View
us-gaap Interest Expense Amount of the cost of borrowed funds accounted for as interest expense. View
us-gaap Liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. View
us-gaap Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. View
us-gaap Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. View
us-gaap Estimated Litigation Liability Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs. View
us-gaap Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. View
us-gaap Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. View
us-gaap Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. View
us-gaap Net Income (Loss) Attributable to Parent, Diluted The portion of profit or loss for the period, net of income taxes, which is attributable to the parent, and includes adjustments resulting from the assumption that dilutive convertible securities were converted, options or warrants were exercised, or that other shares were issued upon the satisfaction of certain conditions. View
us-gaap Preferred Stock, Shares Outstanding Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. View
us-gaap Preferred Stock, Value, Outstanding Value of all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by shareholders, which is net of related treasury stock. May be all or a portion of the number of preferred shares authorized. These shares represent the ownership interest of the preferred shareholders. View
us-gaap Proceeds from Convertible Debt The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder. View
us-gaap Net Income (Loss), Including Portion Attributable to Noncontrolling Interest The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. View
us-gaap Retained Earnings (Accumulated Deficit) The cumulative amount of the reporting entity's undistributed earnings or deficit. View
us-gaap Share-based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. View
us-gaap Share Price Price of a single share of a number of saleable stocks of a company. View
us-gaap Short-term Investments Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current. View
us-gaap Stockholders' Equity Attributable to Parent Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. View
us-gaap Stock Issued The fair value of stock issued in noncash financing activities. View
us-gaap Stock Issued During Period, Value, Conversion of Convertible Securities The gross value of stock issued during the period upon the conversion of convertible securities. View
us-gaap Undistributed Earnings (Loss) Allocated to Participating Securities, Basic Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method. View
us-gaap Warrants and Rights Outstanding Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price. View
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation. View
us-gaap Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. View
us-gaap Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. View
us-gaap Adjustments to Additional Paid in Capital, Warrant Issued Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants. View
us-gaap Share-based Payment Arrangement, Expense Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. View
us-gaap Gain (Loss) on Extinguishment of Debt Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. View
us-gaap Increase (Decrease) in Other Current Assets Amount of increase (decrease) in current assets classified as other. View
us-gaap Other Nonoperating Income (Expense) Amount of income (expense) related to nonoperating activities, classified as other. View
us-gaap Other Prepaid Expense, Current Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. View
us-gaap Proceeds from Issuance of Preferred Stock and Preference Stock Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation. View
us-gaap Stock Issued During Period, Value, New Issues Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. View
us-gaap Accounts Payable, Related Parties Amount for accounts payable to related parties. View
us-gaap Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration. View
us-gaap Deferred Tax Assets, Gross Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. View
us-gaap Deferred Tax Assets, Operating Loss Carryforwards Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. View
us-gaap Deferred Tax Assets, Tax Credit Carryforwards, Research Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards. View
us-gaap Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation. View
us-gaap Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities. View
us-gaap Deferred Tax Assets, Valuation Allowance Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. View
us-gaap Effective Income Tax Rate Reconciliation, Percent Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. View
us-gaap Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Percentage of domestic federal statutory tax rate applicable to pretax income (loss). View
us-gaap Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets. View
us-gaap Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses. View
us-gaap Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement. View
us-gaap Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments. View
us-gaap Increase (Decrease) in Accounts Payable, Trade Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services. View
us-gaap Issuance of Stock and Warrants for Services or Claims Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims. View
us-gaap Notes Payable, Current Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer. View
us-gaap Operating Loss Carryforwards Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. View
us-gaap Other Noncash Expense Amount of expense or loss included in net income that result in no cash flow, classified as other. View
us-gaap Payments of Stock Issuance Costs The cash outflow for cost incurred directly with the issuance of an equity security. View
us-gaap Prepaid Expense and Other Assets, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. View
us-gaap Stock Issued During Period, Value, Issued for Services Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders. View
us-gaap Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. View
us-gaap Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3). View
us-gaap Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. View
us-gaap Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. View
us-gaap Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. View
us-gaap Increase (Decrease) in Prepaid Expenses, Other Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods. View
us-gaap Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method. View
us-gaap Notes Payable, Noncurrent Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion. View
us-gaap Prepaid Insurance Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer. View
us-gaap Repayments of Convertible Debt The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder. View
us-gaap Accounts Receivable, after Allowance for Credit Loss, Current Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. View
us-gaap Cash Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. View
us-gaap Deferred Income, Current Amount of deferred income excluding obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current. View
us-gaap Deferred Income, Noncurrent Amount of deferred income excluding obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent. View
us-gaap Increase (Decrease) in Accounts Receivable The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. View
us-gaap Increase (Decrease) in Deferred Revenue Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable. View
us-gaap Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses. View
us-gaap Income (Loss) from Continuing Operations before Income Taxes, Domestic The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations. View
us-gaap Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. View
us-gaap Income Tax Expense (Benefit) Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. View
us-gaap Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets. View
us-gaap Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates. View
us-gaap Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations. View
us-gaap Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses. View
us-gaap Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement. View
us-gaap Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit). View
us-gaap Increase (Decrease) in Other Operating Assets Amount of increase (decrease) in operating assets classified as other. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. View
us-gaap Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement. View
us-gaap Accrued Professional Fees Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. View
us-gaap Convertible Debt Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company. View
us-gaap Accrued Liabilities, Current Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Accrued Professional Fees, Current Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Additional Paid in Capital Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock. View
us-gaap APIC, Share-based Payment Arrangement, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. View
us-gaap Convertible Notes Payable, Current Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder. View
us-gaap Increase (Decrease) in Accounts Payable, Related Parties The increase (decrease) during the reporting period in the obligations due for goods and services provided by the following types of related parties: a parent company and its subsidiaries, subsidiaries of a common parent, an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence. View
us-gaap Preferred Stock, Shares Issued Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt. View
us-gaap Research and Development Expense The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. View
us-gaap Revenue from Contract with Customer, Excluding Assessed Tax Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. View
us-gaap Accrued Insurance, Current Carrying value as of the balance sheet date of obligations incurred through that date and payable to insurance entities to mitigate potential loss from various risks or to satisfy a promise to provide certain coverage's to employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Derivative Liability, Current Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset. View
us-gaap Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit). View
us-gaap Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates. View
Chart of Accounts => Accounts
Name View
Accounts Payable, Current View
Accounts Payable, Related Parties, Current View
Accrued Liabilities, Current View
Accrued Professional Fees, Current View
Amortization of Debt Discount (Premium) View
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount View
Assets View
Assets, Current View
Cash and Cash Equivalents, at Carrying Value View
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents View
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect View
Cash Equivalents, at Carrying Value View
Class of Warrant or Right, Outstanding View
Common Stock, Par or Stated Value Per Share View
Common Stock, Shares Authorized View
Common Stock, Shares, Issued View
Common Stock, Shares, Outstanding View
Common Stock, Value, Outstanding View
Convertible Notes Payable, Current View
Debt Instrument, Face Amount View
Deferred Costs, Noncurrent View
Dilutive Securities, Effect on Basic Earnings Per Share View
Earnings Per Share, Basic View
Earnings Per Share, Diluted View
Employee-related Liabilities, Current View
Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount View
Fair Value Adjustment of Warrants View
General and Administrative Expense View
Increase (Decrease) in Accounts Payable, Related Parties View
Increase (Decrease) in Accrued Liabilities View
Increase (Decrease) in Deferred Charges View
Interest Expense View
Liabilities View
Liabilities and Equity View
Liabilities, Current View
Estimated Litigation Liability View
Net Cash Provided by (Used in) Financing Activities View
Net Cash Provided by (Used in) Operating Activities View
Net Income (Loss) Attributable to Parent View
Net Income (Loss) Attributable to Parent, Diluted View
Net Income (Loss) Available to Common Stockholders, Basic View
Nonoperating Income (Expense) View
Operating Expenses View
Operating Income (Loss) View
Other Nonoperating Expense View
Paid-in-Kind Interest View
Preferred Stock, Liquidation Preference, Value View
Preferred Stock, Par or Stated Value Per Share View
Preferred Stock, Shares Issued View
Preferred Stock, Shares Outstanding View
Preferred Stock, Value, Outstanding View
Proceeds from Convertible Debt View
Research and Development Expense View
Retained Earnings (Accumulated Deficit) View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number View
Share Price View
Short-term Investments View
Stockholders' Equity Attributable to Parent View
Stock Issued View
Stock Issued During Period, Value, Conversion of Convertible Securities View
Undistributed Earnings (Loss) Allocated to Participating Securities, Basic View
Warrants and Rights Outstanding View
Weighted Average Number Diluted Shares Outstanding Adjustment View
Weighted Average Number of Shares Outstanding, Diluted View
Weighted Average Number of Shares Outstanding, Basic View
Accrued Insurance, Current View
Adjustments to Additional Paid in Capital, Warrant Issued View
Share-based Payment Arrangement, Expense View
Gain (Loss) on Extinguishment of Debt View
Increase (Decrease) in Other Current Assets View
Other Nonoperating Income (Expense) View
Other Prepaid Expense, Current View
Proceeds from Issuance of Preferred Stock and Preference Stock View
Stock Issued During Period, Value, New Issues View
Accounts Payable, Related Parties View
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs View
Deferred Tax Assets, Gross View
Deferred Tax Assets, Operating Loss Carryforwards View
Deferred Tax Assets, Tax Credit Carryforwards, Research View
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost View
Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities View
Deferred Tax Assets, Valuation Allowance View
Derivative Liability, Current View
Effective Income Tax Rate Reconciliation, Percent View
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent View
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent View
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent View
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent View
Effective Income Tax Rate Reconciliation, Other Adjustments, Percent View
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent View
Increase (Decrease) in Accounts Payable, Trade View
Issuance of Stock and Warrants for Services or Claims View
Notes Payable, Current View
Operating Loss Carryforwards View
Other Noncash Expense View
Payments of Stock Issuance Costs View
Prepaid Expense and Other Assets, Current View
Stock Issued During Period, Value, Issued for Services View
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount View
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings View
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances View
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements View
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value View
Increase (Decrease) in Prepaid Expenses, Other View
Notes Payable, Noncurrent View
Prepaid Insurance View
Repayments of Convertible Debt View
Accounts Receivable, after Allowance for Credit Loss, Current View
Cash View
Deferred Income, Current View
Deferred Income, Noncurrent View
Increase (Decrease) in Accounts Receivable View
Increase (Decrease) in Deferred Revenue View
Payment, Tax Withholding, Share-based Payment Arrangement View
Restricted Stock, Value, Shares Issued Net of Tax Withholdings View
Other Inventory, in Transit, Gross View
Accrued Salaries, Current View
Deferred Tax Assets, Net of Valuation Allowance View
Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent View
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent View
Income (Loss) from Continuing Operations before Income Taxes, Domestic View
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest View
Income Tax Expense (Benefit) View
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount View
Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount View
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount View
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount View
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount View
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount View
Increase (Decrease) in Other Operating Assets View
Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation View
Accrued Professional Fees View
Convertible Debt View
Additional Paid in Capital View
APIC, Share-based Payment Arrangement, Increase for Cost Recognition View
Preferred Stock, Shares Authorized View
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest View
Revenue from Contract with Customer, Excluding Assessed Tax View
Share-based Payment Arrangement, Noncash Expense View
Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price View